Tomoyuki Miura

Dr. Tomoyuki Miura

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2015 in Scientific Reports
Verified
Journal Article
Open access
YKYusuke Kakizoe
Yusuke Kakizoe
SNShinji Nakaoka
Shinji Nakaoka
CBCatherine A. A. Beauchemin
Catherine A. A. Beauchemin
SMSatoru Morita
Satoru Morita
HMHiromi Mori
Hiromi Mori
SIShingo Iwami
Shingo Iwami
The time elapsed between successful cell infection and the start of virus production is called the eclipse phase. Its duration is specific to each virus strain and, along with an effective virus production rate, plays a key role in infection kinetics. How the eclipse phase varies amongst cells infected with the same virus strain and therefore how best to mathematically represent its duration is not clear. Most mathematical models either neglect this phase or assume it is exponentially distributed, such that at least some if not all cells can produce virus immediately upon infection. Biologically, this is unrealistic (one must allow for the translation, transcription, export, etc. to take place), but could be appropriate if the duration of the eclipse phase is negligible on the time-scale of the infection. If it is not, however, ignoring this delay affects the accuracy of the mathematical model, its parameter estimates and predictions. Here, we introduce a new approach, consisting in a carefully designed experiment and simple analytical expressions, to determine the duration and distribution of the eclipse phase in vitro. We find that the eclipse phase of SHIV-KS661 lasts on average one day and is consistent with an Erlang distribution.

1 January 2012 in Frontiers in Microbiology
Verified
Journal Article
Open access
SIShingo Iwami
Shingo Iwami
KSKei Sato
Kei Sato
RBRob De Boer
Rob De Boer
KAKazuyuki Aihara
Kazuyuki Aihara
TMTomoyuki Miura
Tomoyuki Miura
YKYoshio Koyanagi
Yoshio Koyanagi
Current in vitro cell culture studies of viral replication deliver detailed time courses of several virological variables, like the amount of virions and the number of target cells, measured over several days of the experiment. Each of these time points solely provides a snap-shot of the virus infection kinetics and is brought about by the complex interplay of target cell infection, and viral production and cell death. It remains a challenge to interpret these data quantitatively and to reveal the kinetics of these underlying processes to understand how the viral infection depends on these kinetic properties. In order to decompose the kinetics of virus infection, we introduce a method to “quantitatively” describe the virus infection in in vitro cell cultures, and discuss the potential of the mathematical based analyses for experimental virology.

1 July 2015 in Journal of Theoretical Biology
Verified
Journal Article
Closed access
YKYusuke Kakizoe
Yusuke Kakizoe
SMSatoru Morita
Satoru Morita
SNShinji Nakaoka
Shinji Nakaoka
Yasuhiro TakeuchiYasuhiro Takeuchi
Yasuhiro Takeuchi
KSKei Sato
Kei Sato
SIShingo Iwami
Shingo Iwami

1 March 2001 in Virology
Verified
Journal Article
Closed access
PDF file
IKIouri L. Kozyrev
Iouri L. Kozyrev
KIKentaro Ibukia
Kentaro Ibukia
TSToshihide Shimadab
Toshihide Shimadab
TKTakeo Kuwataa
Takeo Kuwataa
TTTaichiro Takemuraa
Taichiro Takemuraa
TMTomoyuki Miura
Tomoyuki Miura

1 March 2010 in Virology
Verified
Journal Article
Closed access
KMKenta Matsuda
Kenta Matsuda
KIKatsuhisa Inaba
Katsuhisa Inaba
YFYoshinori Fukazawa
Yoshinori Fukazawa
MMMegumi Matsuyama
Megumi Matsuyama
KIKentaro Ibuki
Kentaro Ibuki
TMTomoyuki Miura
Tomoyuki Miura

1 July 2005 in Journal of General Virology
Verified
Journal Article
Closed access
TTTaichiro Takemura
Taichiro Takemura
MEMichel Ekwalanga
Michel Ekwalanga
BBBlaise Bikandou
Blaise Bikandou
EIEiji Ido
Eiji Ido
YYYumi Yamaguchi-Kabata
Yumi Yamaguchi-Kabata
TMTomoyuki Miura
Tomoyuki Miura
In order to understand primate lentivirus evolution, characterization of additional simian immunodeficiency virus (SIV) strains is essential. Here, an SIV from a black mangabey (Lophocebus aterrimus) originating from the Democratic Republic of Congo was analysed phylogenetically. The monkey had cross-reactive antibodies against human immunodeficiency virus type 1 (HIV-1) and HIV-2. The viral pol region sequence was amplified by nested PCR and sequence analysis confirmed that it was related to known SIV sequences. This is the first report to characterize genetically an SIV from the monkey genus Lophocebus. Phylogenetic analysis of the pol region revealed that this novel SIV, designated SIVbkm, fell into the SIVsyk and SIVgsn virus group, containing viruses isolated from the genus Cercopithecus, and suggests that cross-species transmission has occurred between species of the genera Lophocebus and Cercopithecus.